Keywords
Awards & distinctions
- 2019 Named one of the “40 in their 40s” in the Notable Women in Competition Professionals list. Selected by @W_AT_World as one of the Top 40 female economists in Europe, the Americas, and Africa.
Team
CEDP
Biography
Margaret Kyle is a researcher specializing in the analysis of innovation policies, intellectual property rights (IPR), and their impact on pharmaceutical markets and access to medicines. Her work examines, in particular, the effects of international agreements—such as the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS)—on generic competition, patenting strategies, and price dynamics in both developing and developed countries. Her research highlights the mechanisms through which regulations influence innovation, the diffusion of medical technologies, and inequalities in access to treatments. She also explores the interactions between public policy, markets, and firm behavior, using quantitative methods to evaluate the effectiveness of interventions in public health and intellectual property.
Publication(s)
-
2026
TRIPS, pharmaceutical patents, and generic competition in India DOI : 10.1093/haschl/qxaf239
-
2025
Lessons for the United States from Pharmaceutical Regulation Abroad DOI : 10.1257/jep.20241418
-
2024
Are intellectual property rights working for society? DOI : 10.1016/j.respol.2023.104936
-
2024
Hot tub time machine? What role for Towercast in EU merger control DOI : 10.1093/jeclap/lpae057
-
2022
Incentives for pharmaceutical innovation: What's working, what's lacking DOI : 10.1016/j.ijindorg.2022.102850
-
2022
Trade in Intellectual Property-Intensive Goods DOI : 10.1017/9781108780919.018
-
2020
The alignment of innovation policy and social welfare: Evidence from pharmaceuticals DOI : 10.1086/705640
-
2019
The Single Market in Pharmaceuticals DOI : 10.1007/s11151-019-09694-6
-
2019
The more we die, the more we sell? A simple test of the home-market effect DOI : 10.1093/qje/qjz003
-
2018
Are Important Innovations Rewarded? Evidence from Pharmaceutical Markets DOI : 10.1007/s11151-018-9639-7
-
2017
Strategic interaction among governments in the provision of a global public good DOI : 10.1016/j.jpubeco.2017.10.009
-
2017
Is American health care uniquely inefficient? Evidence from prescription drugs DOI : 10.1257/aer.p20171086
-
2016
Competition and the efficiency of markets for technology DOI : 10.1287/mnsc.2015.2191
-
2014
Mergers and Alliances in the Biopharmaceuticals Industry DOI : 10.1016/B978-0-12-375678-7.01204-9
-
2013
Intellectual property protection and the geography of trade DOI : 10.1111/joie.12027
-
2012
Investments in pharmaceuticals before and after TRIPS DOI : 10.1162/REST_a_00214
-
2012
Assessing the population health impact of market interventions to improve access to antiretroviral treatment DOI : 10.1093/heapol/czr058
-
2012
Mergers, Acquisitions, and Alliances DOI : 10.1093/oxfordhb/9780199742998.013.0018
-
2011
Strategic responses to parallel trade DOI : 10.2202/1935-1682.2629
-
2011
Markets for Pharmaceutical Products DOI : 10.1016/B978-0-444-53592-4.00012-8
-
2011
Evolving brand-name and generic drug competition may warrant a revision of the Hatch-Waxman Act DOI : 10.1377/hlthaff.2010.0270
-
2010
Intervening in global markets to improve access to HIV/AIDS treatment: An analysis of international policies and the dynamics of global antiretroviral medicines markets DOI : 10.1186/1744-8603-6-9
-
2008
Mergers and alliances in pharmaceuticals: Effects on innovation and R&D productivity
-
2008
Does reimportation reduce price differences for prescription drugs? Lessons from the European Union DOI : 10.1111/j.1475-6773.2008.00838.x
-
2007
Would greater transparency and uniformity of health care prices benefit poor patients? DOI : 10.1377/hlthaff.26.5.1384
-
2007
Generic competition and market exclusivity periods in pharmaceuticals DOI : 10.1002/mde.1356
-
2007
Pharmaceutical price controls and entry strategies DOI : 10.1162/rest.89.1.88
-
2006
Surviving the gales of creative destruction: The determinants of product turnover DOI : 10.1002/smj.512
-
2006
Objective and self-report work performance measures: A comparative analysis DOI : 10.1108/17410400610671426
-
2006
The role of firm characteristics in pharmaceutical product launches DOI : 10.1111/j.1756-2171.2006.tb00033.x
-
2005
How do firms gain and retain their dominant position?
-
2002
Deregulating direct-to-consumer marketing of prescription drugs: Effects on prescription and over-the-counter product sales DOI : 10.1086/368004
Teaching
Economic Issues
The approach of this course is to address economic issues by starting with broad themes. The course will be spread over 9 mornings, with one theme covered per morning. Each theme will be led by a CERNA faculty member and researcher with expertise in the subject. However, one or two external speakers will also be invited. The list of themes is as follows: Growth and innovation. Globalization and international trade. Finance, currency, and banking. Guest speaker. Labor and employment. Social protection and inequality. Institutional economics. The nature of the firm. Energy and the environment. The digital economy. Development economics.
Introduction to Economics
Classes will be organized in half-day sessions, consisting of a 1.5-hour lecture followed by a 1.5-hour tutorial during which students will complete application exercises. Students will also participate in two educational games (classroom games), one introducing competitive market theory and the other introducing game theory. This course is a condensed version of the former Microeconomics – Economic Analysis course. It must be scheduled before the Economic Problems course, as it provides the tools that will be used in that course.
Elective Course Period (October and January)
Technology and Innovation Strategy
Case Studies: - Competition in R&D - Technology Adoption - R&D Organization - Two-sided Markets - Intellectual Property Strategies
Industrial Economics (ECOINDUS) track
The first part of the program aims to spark students’ curiosity about industrial economics in preparation for the second-year course. In the third year, the course topics are explored in greater depth through thematic seminars, analysis of seminal articles, and lectures. At the same time, business and market issues are explored, including negotiation games, marketing, intellectual property, public policy, regulation, and corporate finance. Each year, a joint research project is conducted on concrete topics—quality differentiation in wine, local or European policies for telecommunications deployment, the liberalization of the gambling market, the vertical organization of mass retail, and so on. These serve as a common thread throughout the periods dedicated to the specialization. At the end of the program, the third-year capstone internship involves applying an industrial economics approach to a real-world business problem. The introduction of digital technologies, changes in the pricing of goods and services, and regulatory adjustments are often at the heart of the issues addressed. The Second-Year Specialization First industrial study: a series of interviews with industry representatives addressing a current economic issue (competition from New World wines, the rise of online gambling, challenges to the fixed book price system, the impact of the space sector on French Guiana’s economy, China’s real estate market…). The study is based on this current issue: preparation (reading, presentations), interviews with industry representatives and site visits, formulation of the research question, and collective drafting of the final report submitted to the interviewees. The Third-Year Elective In-depth study of the Industrial Economics course: seminars on the economics of institutions and intellectual property, econometrics, game theory, lectures by foreign economists, case studies... Introduction to Business: negotiation simulations, business simulations, industrial financing, a case study on patents, strategy case studies, and lectures by industry executives discussing strategic decisions they helped make and implement. Second industrial survey (same principle as in 2A). Internship focused on economic analysis within a company. The topics are proposed by the company and relate to changes in competition, markets, and regulations; the firm’s competitive positioning; and its development strategies. Some representative elective topics covered in recent years: Return on advertising investments (DDB) Optimization of personnel expenses for a telecommunications operator (COLT) Optimization of auto insurance contract cancellations (Pacifica) Market structure, competition, and dynamics of the television sector in Europe (ABN Amro) Valuation of a publisher’s catalog (Hachette). Outlook for the public-sector IT outsourcing market (ATOS Origin). Growth prospects in the specialty paper market (ArjoWiggins)
PhD supervision
- 2024 Three Essays in the Economics of Innovation KAISER Alexis
- 2024 Study of the R&D implantation strategies of multinational firms. ROBERT Guillaume
- 2024 The Impact of Drug Supply on Pharmaceutical Consumption, Competition, and Innovation: The Case of China. EFIMOVA Ekaterina
- 2019 Pharmaceutical products: Reimbursement, Use, and Contribution to Health Improvement EL AYADI Nassireddine
- 2018 Essay on Access to Energy and the Competition from Chinese Imports in Africa HOUNYONOU Quentin
- 2018 Trade liberalization and foreign direct investment: the case of Morocco JANATI IDRISSI Tarek
